senktide has been researched along with scopolamine hydrobromide in 6 studies
| Studies (senktide) | Trials (senktide) | Recent Studies (post-2010) (senktide) | Studies (scopolamine hydrobromide) | Trials (scopolamine hydrobromide) | Recent Studies (post-2010) (scopolamine hydrobromide) |
|---|---|---|---|---|---|
| 292 | 1 | 50 | 7,548 | 563 | 1,401 |
| Protein | Taxonomy | senktide (IC50) | scopolamine hydrobromide (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.003 | |
| Muscarinic acetylcholine receptor M1 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M3 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M4 | Rattus norvegicus (Norway rat) | 0.006 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.0006 | |
| Muscarinic acetylcholine receptor M5 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M2 | Rattus norvegicus (Norway rat) | 0.006 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0026 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dourish, CT; Iversen, SD; Stoessl, AJ | 1 |
| Bornstein, JC; Furness, JB; Johnson, PJ; Yuan, SY | 1 |
| Kameyama, T; Shinkai, N; Ukai, M | 3 |
| Barros, M; de Souza Silva, MA; Huston, JP; Schäble, S; Tomaz, C | 1 |
6 other study(ies) available for senktide and scopolamine hydrobromide
| Article | Year |
|---|---|
The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.
Topics: Animals; Brain Chemistry; Dose-Response Relationship, Drug; Haloperidol; Hydroxydopamines; Injections, Subcutaneous; Male; Oxidopamine; Parasympathetic Nervous System; Peptide Fragments; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Tachykinin; Scopolamine; Stereotyped Behavior; Substance P; Yawning | 1988 |
Analysis of contributions of acetylcholine and tachykinins to neuro-neuronal transmission in motility reflexes in the guinea-pig ileum.
Topics: Acetylcholine; Afferent Pathways; Animals; Efferent Pathways; Female; Gastrointestinal Motility; Guinea Pigs; Hexamethonium; Ileum; Male; Membrane Potentials; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Nicotinic Antagonists; Peptide Fragments; Receptors, Neurokinin-3; Reflex; Scopolamine; Substance P; Synaptic Transmission; Tachykinins | 1996 |
Neurokinin A and senktide attenuate scopolamine-induced impairment of spontaneous alternation performance in mice.
Topics: Amnesia; Animals; Male; Maze Learning; Mice; Neurokinin A; Peptide Fragments; Psychomotor Performance; Receptors, Neurokinin-2; Receptors, Neurokinin-3; Scopolamine; Substance P | 1996 |
Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amnesia; Animals; Benzazepines; Dopamine Agonists; Dopamine Antagonists; Male; Memory; Mice; Neurokinin A; Peptide Fragments; Phenethylamines; Receptors, Cholinergic; Receptors, Dopamine D1; Receptors, Dopamine D2; Scopolamine; Substance P; Sulpiride; Tachykinins | 1998 |
Ameliorative effects of tachykinins on scopolamine-induced impairment of spontaneous alternation performance in mice.
Topics: Animals; Male; Mice; Muscarinic Antagonists; Naloxone; Naltrexone; Narcotic Antagonists; Neurokinin A; Peptide Fragments; Psychomotor Performance; Scopolamine; Substance P; Tachykinins | 1998 |
The NK3 receptor agonist senktide ameliorates scopolamine-induced deficits in memory for object, place and temporal order.
Topics: Animals; Male; Maze Learning; Memory; Memory Disorders; Peptide Fragments; Rats; Rats, Wistar; Receptors, Neurokinin-3; Recognition, Psychology; Scopolamine; Substance P | 2012 |